These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 360766)

  • 21. [Diligan in the therapy of vertiginous conditions].
    Hahn A
    Cesk Otolaryngol; 1978 Oct; 27(5):303-6. PubMed ID: 709660
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy and tolerability of a fixed low-dose combination of cinnarizine and dimenhydrinate in the treatment of vertigo: a 4-week, randomized, double-blind, active- and placebo-controlled, parallel-group, outpatient study.
    Pytel J; Nagy G; Tóth A; Spellenberg S; Schwarz M; Répassy G
    Clin Ther; 2007 Jan; 29(1):84-98. PubMed ID: 17379049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Late dyskinesias. 3 cases after treatment with thiethylperazine].
    Dupont E
    Ugeskr Laeger; 1972 Jul; 134(31):1613-5. PubMed ID: 5052353
    [No Abstract]   [Full Text] [Related]  

  • 24. [The treatment of vertiginous syndromes in patients with cranial injuries with a phenothiazine derivative (thiethylperazine)].
    Faggian I
    Minerva Otorinolaringol; 1967; 17(11):236-40. PubMed ID: 5304761
    [No Abstract]   [Full Text] [Related]  

  • 25. Side effects of some antimotion sickness drugs as measured by psychomotor test and questionnaires.
    Kennedy RE; Wood CD; Graybiel A; McDonough RB
    Aerosp Med; 1966 Apr; 37(4):408-11. PubMed ID: 5954449
    [No Abstract]   [Full Text] [Related]  

  • 26. Transdermal scopolamine in the treatment of acute vertigo.
    Babin RW; Balkany TJ; Fee WE
    Ann Otol Rhinol Laryngol; 1984; 93(1 Pt 1):25-7. PubMed ID: 6703595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the adverse reactions and efficacy of long-term treatment with flupirtine: preliminary results of an ongoing twelve-month study with 200 patients suffering from chronic pain states in arthrosis or arthritis.
    Herrmann WM; Kern U; Aigner M
    Postgrad Med J; 1987; 63 Suppl 3():87-103. PubMed ID: 2451818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A nystagmographic study of thiethylperazine in normal subjects and in patients with vertigo.
    Bertrand RA
    Pract Otorhinolaryngol (Basel); 1966; 28(6):437-47. PubMed ID: 5959150
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical studies on the use of torecan in ear diseases].
    Kossowski S
    Wiad Lek; 1969 Sep; 22(18):1695-9. PubMed ID: 5364854
    [No Abstract]   [Full Text] [Related]  

  • 30. [Letter: Little known side-effect of various antivertiginous agents].
    Tignol J; Rougier A; Henry P; Loiseau P
    Nouv Presse Med; 1974 Jun; 3(24):1568-9. PubMed ID: 4849086
    [No Abstract]   [Full Text] [Related]  

  • 31. [Results obtained with thiethylperazine in vestibular tests].
    Etaner R; Cevanşir B; Murat F
    Turk Tip Cemiy Mecm; 1966 Dec; 32(12):707-10. PubMed ID: 5298620
    [No Abstract]   [Full Text] [Related]  

  • 32. [Acute dystonia due to neuroleptics in the treatment of vertigo: apropos 2 cases].
    Pérez N; Fernández S; Legarda I; García-Tapia R
    Acta Otorrinolaringol Esp; 1992; 43(4):287-9. PubMed ID: 1419163
    [No Abstract]   [Full Text] [Related]  

  • 33. [Trimetazidine versus betahistine in vestibular vertigo. A double blind study].
    Kluyskens P; Lambert P; D'Hooge D
    Ann Otolaryngol Chir Cervicofac; 1990; 107 Suppl 1():11-9. PubMed ID: 2240994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efficacy and safety of dotarizine vs. cinnarizine in the symptomatic treatment of acute balance disorders (common vertigo)].
    Perelló E; Esteller E; Colls A; Magriñá C; Massegur H; Lluansí J; Casamitjana JF; Lao X; Roca-Ribas F; Miró N; Prades J; Herrero E; Molá O; Torres J; Márquez M; Ortiz JA
    An Otorrinolaringol Ibero Am; 1998; 25(3):291-310. PubMed ID: 9658668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The management of senility dizziness].
    Bollig L; Iven A; Schmidt R
    Med Klin; 1967 Sep; 62(35):1350 passim. PubMed ID: 5593019
    [No Abstract]   [Full Text] [Related]  

  • 36. Betahistine in peripheral vertigo: a double-blind, placebo-controlled, cross-over study of Serc versus placebo.
    Canty P; Valentine J
    J Laryngol Otol; 1981 Jul; 95(7):687-92. PubMed ID: 7019369
    [No Abstract]   [Full Text] [Related]  

  • 37. Thiethylperazine and tardive dyskinesia.
    Sulkava R
    Acta Neurol Scand; 1984 Nov; 70(5):369-72. PubMed ID: 6507047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of sixteen anti-motion sickness drugs under controlled laboratory conditions.
    Wood CD; Graybiel A
    Aerosp Med; 1968 Dec; 39(12):1341-4. PubMed ID: 4881887
    [No Abstract]   [Full Text] [Related]  

  • 39. [Extrapyramidal side effects after long-term treatment with thiethylperazine].
    Brennum J
    Ugeskr Laeger; 1988 Nov; 150(46):2827. PubMed ID: 3206698
    [No Abstract]   [Full Text] [Related]  

  • 40. The effects of transtympanic micropressure treatment in people with unilateral Meniere's disease.
    Gates GA; Green JD; Tucci DL; Telian SA
    Arch Otolaryngol Head Neck Surg; 2004 Jun; 130(6):718-25. PubMed ID: 15210552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.